The deal between Avicanna's majority-owned subsidiary Santa Marta Golden Hemp and the established Chilean pharmaceutical company further solidifies Avicanna's and Knop's collaboration.
Since 2018, Avicanna and Knop have developed a collaborative enterprise that has led to commercial imports of Avicanna's API, including CBD and THC, which have been used in the development, production and commercialization of several cannabinoid-based products.
Recent Moves
In the meantime, Avicanna also expanded its Rho Phyto-branded medical cannabis products into the Caribbean region after a successful initial export to its distribution partner, Bryden Stokes Limited in Barbados.
To wrap up the previous year, the company launched its re+PLAY sports recovery-based CBD brand through a partnership with Harrington Wellness, founded by NBA veteran Al Harrington.
The company recently revealed that the third quarter was its most successful to date, with roughly CA$1 ($987,967) in revenue, representing a gross revenue increase of 24% sequentially and 260% year-over-year.
AVCNF Price Action
Avicenna'sa shares traded 7.14% higher at $0.6 per share at the time of writing on Friday.
Photo: Courtesy of Cytonn Photography on Unsplash
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
